A team including KI member Christopher Love customized blood biopsies using genetic profiles of patients' tumors. A study published in Clinical Cancer Research and funded in part by the Bridge Project showed that the biopsies monitor up to hundreds of different mutations, potentially detecting cancer recurrence years ahead of traditional approaches.